Boryung Corporation (KRX:003850)
10,400
+70 (0.68%)
Feb 21, 2025, 9:00 AM KST
Boryung Revenue
Boryung had revenue of 271.03B KRW in the quarter ending September 30, 2024, with 30.10% growth. This brings the company's revenue in the last twelve months to 991.43B, up 19.47% year-over-year. In the year 2023, Boryung had annual revenue of 859.63B with 13.04% growth.
Revenue (ttm)
991.43B
Revenue Growth
+19.47%
P/S Ratio
0.69
Revenue / Employee
646.73M
Employees
1,533
Market Cap
871.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 859.63B | 99.15B | 13.04% |
Dec 31, 2022 | 760.48B | 133.20B | 21.23% |
Dec 31, 2021 | 627.28B | 65.41B | 11.64% |
Dec 31, 2020 | 561.87B | 37.60B | 7.17% |
Dec 31, 2019 | 524.27B | 63.87B | 13.87% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
SK Biopharmaceuticals | 511.33B |
Yuhan | 2,008.84B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanmi Science | 1,283.65B |
Hanall Biopharma | 134.24B |